Patients affected by new coronavirus infectious disease (COVID) were mostly hospitalized in ICU. This infection seems to cause widespread organ injury (i.e acute renal injury, neurological disorders, pulmonary embolism,…). It is therefore necessary to provide a framework for the follow up of patients. Moreover SARS-CoV-2 infection consequences remain unknow at this time. Study hypothesis is that COVID alters determining factors (physical or psychological) of quality of life after ICU hospitalisation. The aim of the study is to assess quality of life 3 months after ICU hospitalization. Secondary purposes of the study are 1) assessment of quality of life 6 months and the evolution between the third and the sixth months after ICU hospitalization 2) description patients care after 3 and 6 months ICU left and their clinical status 3) convening and providing a "platform" within several physicians (neurologist, biologist, pneumologist…) will be able to follow up patients and perform complementary investigations according to patients injuries.
Other: quality of live assessment
quality of live assessment 3 moth and 6 moth after ointensive care hospitalisation using SF36.
Inclusion criteria:
- Subject male or female ≥ 18 years old
- Patient hospitalized in the anesthesia-resuscitation department of the NHC for
COVID-19 from March 1, 2020.
- Patient (or his legal representative) having given his consent for the use of his data
for the purposes of this research.
exclusion criteria:
- Subject not hospitalized in intensive care
- Patient's refusal to participate in the study
- Inability to give informed information to the subject (subject in an emergency,
difficulty understanding the subject, etc.)
- Subject under low protection
Hôpitaux Universitaires de Strasbourg (Nouvel Hôpital Civil)
Strasbourg, France